跳至主要内容
临床试验/ISRCTN34308454
ISRCTN34308454已完成未知

Pre-reactivation propranolol therapy to reduce post-traumatic stress disorder in Nepalese torture survivors

Douglas Mental Health University Institute0 个研究点目标入组 46 人开始时间: 2018年4月12日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
46

研究概览

简要总结

2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34479508/ (added 06/09/2021)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Male or female 25-65 years old
  • 2. Fluency in a Nepali language
  • 3. Having experienced a potentially traumatic event according to the CAPS trauma list more than 6 months ago
  • 4. Evidence of trauma-related distress, or impaired functioning, not present before the index event
  • 5. Evidence that the candidate participant understands the study procedures
  • 6. Signed informed consent form, OR a document signed by the site principal investigator attesting that consent was given orally in the presence of a witness

排除标准

  • 1. Resting heart rate < 60 Beats Per Minute
  • 2. Resting systolic blood pressure < 100 mm Hg
  • 3. A PCL score below 50.
  • 4. A CGI severity score below 4 (Moderately ill)
  • 5. Not meeting the criteria for chronic PTSD at the time of randomization (visit 2)
  • 6. Currently suicidal (i.e. a score of 3 or 4 on item 7 on the HSCL) or homicidal
  • 7. A history of congestive heart failure, hypoglycemic medication-requiring diabetes, chronic bronchitis, emphysema, or asthma
  • 8. Acute morbidity that leads to disabilityand that requires immediate medical treatment (e.g., gastric acid disease)
  • 9. Previous adverse reaction to a ß-adrenergic blocker
  • 10. Presence of drugs of abuse, viz., alcohol, opiates, marijuana, cocaine, or amphetamines, as determined by collateral informants
  • 11. Women of child-bearing potential who are not using an acceptable birth-control method, including abstinence (condoms will be provided for free)
  • 12. Positive pregnancy test
  • 13. Breastfeeding
  • 14. Contra-indicating neuropsychiatric condition, e.g., current psychotic, bipolar, melancholic, memory problems or substance dependence or abuse disorder
  • 15. Current use of medication that involve potentially dangerous interactions with propranolol, including, other ß-adrenergic blockers, anti-arrythmics, and calcium channel blockers
  • 16. Potent P450 2D6 inhibitors will not be exclusionary, because participants will receive only a single day’s dose of propranolol under observation, so that build-up of plasma levels over time due to decreased metabolism will not be a problem
  • 17. Current use of a medication that may involve potentially dangerous interactions with paroxetine, such as cimetidine, amitriptyline, desipramine, risperidone, atomoxetine, thioridazine, a MAOI, or pimozide

研究者

相似试验

Defeating the giant with a slingshot: testing a new... | 临床试验